chr16-56453274-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018233.4(OGFOD1):āc.166A>Gā(p.Met56Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000319 in 1,608,004 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018233.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OGFOD1 | NM_018233.4 | c.166A>G | p.Met56Val | missense_variant | 2/13 | ENST00000566157.6 | NP_060703.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OGFOD1 | ENST00000566157.6 | c.166A>G | p.Met56Val | missense_variant | 2/13 | 1 | NM_018233.4 | ENSP00000457258 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152268Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000233 AC: 57AN: 245064Hom.: 0 AF XY: 0.000227 AC XY: 30AN XY: 132332
GnomAD4 exome AF: 0.000324 AC: 472AN: 1455736Hom.: 1 Cov.: 30 AF XY: 0.000309 AC XY: 224AN XY: 723970
GnomAD4 genome AF: 0.000269 AC: 41AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74390
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.166A>G (p.M56V) alteration is located in exon 2 (coding exon 2) of the OGFOD1 gene. This alteration results from a A to G substitution at nucleotide position 166, causing the methionine (M) at amino acid position 56 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at